Focus: LGC Biosearch Technologies is a public biotechnology company specializing in custom oligonucleotide synthesis, headquartered in Lystrup, Denmark, with a focus on neurology applications.
Profile data last refreshed 12h ago · AI intelligence enriched 1w ago
Hot — 113 jobs added in 30d
Net +63 (113 new, 50 removed). Aggressive expansion phase.
Strong fit for synthetic biology specialists and supply-chain professionals in a stable CDMO; less appealing for those seeking pipeline-driven career trajectories or clinical impact.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for LGC Biosearch Technologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from LGC Biosearch Technologies's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo